EMMA Capital Group completes acquisition of Romanian company Diamedix

EMMA Capital Group, through its company EMMA ZETA, has become the majority owner of Diamedix, one of Romania’s largest independent medical equipment distributors. The acquisition further strengthens EMMA Capital’s position in the sector, which it entered in January 2024 by acquiring the Serbian company Magna Pharmacia, one of the largest distributors of medical equipment and technology in Southeastern Europe.

Diamedix specialises in the provision of instruments to laboratories and the subsequent supply of laboratory tests. This segment accounts for about 90% of its revenue, which reached EUR 67 million in 2024.

Like Magna Pharmacia, Diamedix represents leading global medical device manufacturers such as Siemens Healthineers, Horiba and Copan, among others. It also has offices in Moldova, Bulgaria and Ukraine, thereby extending EMMA ZETA’s reach to five countries in the Southern and Southeastern European region. The total sales of all the companies currently EMMA ZETA reached EUR 220 million in 2024.

“The acquisition of Diamedix signifies a great development impulse for us. Thanks to it, we will become one of the most important players on the market in the whole region, and in the future, this segment may gradually become another main pillar of EMMA Capital Group’s entire business,” says Michal Houšt', partner at EMMA Capital.

EMMA Capital Group holds a 65% stake in EMMA ZETA, which bought 100% of Diamedix. The remaining 35% is owned by the founder of Magna Pharmacia, Ms. Jasna Stanivuk.

The sellers were the Spanish private equity group Buenavista Equity Partners, operating until recently under the name GED (80%), and the founder of Diamedix, Mr. Vasileios Chrelias (20%). Both parties have agreed that Mr. Chrelias will continue to lead the company during the transition period, which is expected to last until the end of this year.

EMMA Capital is a private investment holding founded in 2012 by Jiří Šmejc. In recent years, it has focused chiefly on markets in the European Union, but is also present in other markets in Europe and Asia. It usually plays an active role in companies where it acquires an equity stake, participating in their management, development and in any eventual restructuring. EMMA’s investment priority is retail and customer-oriented companies, while it is also successfully penetrating the B2B segment.

Contact:

Pavel Zuna
EMMA Capital
Email: [email protected]